A Phase I Study of GZR18 Injection in Healthy Subjects

Clinical trial NCT06548997 · COMPLETED

Trial details

NCT number: NCT06548997
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Overweight and Obesity

Start date: 2021-12-02
Primary completion: 2022-10-20
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.